Breast cancer; her2-positive; metastatic Clinical Trials
Conditions / Breast cancer; her2-positive; metastatic
Delta Trials tracks 1 clinical trial for Breast cancer; her2-positive; metastatic in its publicly accessible dataset. Among the listed trials, 0 open for participant enrollment and 0 trials have reached completion. This research is carried out at 229 clinical sites around the world. An additional 1 trial have active registrations outside the recruiting and completed categories. This dataset is refreshed continuously as trial statuses are updated on ClinicalTrials.gov, capturing longitudinal changes in the research landscape.
Trial Status
1
Total Trials
0
Recruiting
0
Completed
1
Other Active
0
Terminated since 2020
229
Study Locations
Browse by location (229 total)
- Leuven, Belgium 1 trialAll trials in Leuven, Belgium
- Haifa, Israel 1 trialAll trials in Haifa, Israel
- Saint-Cloud, France 1 trialAll trials in Saint-Cloud, France
- Milan, Italy 1 trialAll trials in Milan, Italy
- Dammam, Saudi Arabia 1 trialAll trials in Dammam, Saudi Arabia
- Okayama, Japan 1 trialAll trials in Okayama, Japan
- Mar del Plata, Argentina 1 trialAll trials in Mar del Plata, Argentina
- Freiburg Im Breisgau, Germany 1 trialAll trials in Freiburg Im Breisgau, Germany
- Sorocaba, Brazil 1 trialAll trials in Sorocaba, Brazil
- Dallas, United States 1 trialAll trials in Dallas, United States
- Manchester, United Kingdom 1 trialAll trials in Manchester, United Kingdom
- Mysuru, India 1 trialAll trials in Mysuru, India
- Longmont, United States 1 trialAll trials in Longmont, United States
- Alc. Cuauhtémoc, Mexico 1 trialAll trials in Alc. Cuauhtémoc, Mexico
- Charleroi, Belgium 1 trialAll trials in Charleroi, Belgium
- Denton, United States 1 trialAll trials in Denton, United States
- Niigata, Japan 1 trialAll trials in Niigata, Japan
- Ramat Gan, Israel 1 trialAll trials in Ramat Gan, Israel
- Yinchuan, China 1 trialAll trials in Yinchuan, China
- Kitchener, Canada 1 trialAll trials in Kitchener, Canada